ArticleDiscover oncology2025

RRP9 promotes prostate cancer metastasis and epithelial-mesenchymal transition through activation of the AKT/GSK3β/β-Catenin signaling pathway.

Zijian Da et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.